These data demonstrate that SIRT4 is sufficient to reprogram α2δ1- cells into TICs, which depends on its enzymatic activity, and is essential for the subsequent maintenance of stem cell-like properties of α2δ1+ HCC TICs. The gene discussed is SIRT4; the disease is hepatocellular carcinoma.